{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT00447460",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CSM/EICH2005"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "EudraCT Number: 2005-003674-14"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "University of Salamanca",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell",
      "OfficialTitle": "A Phase I/II Trial in Treating Patients With Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2007",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "January 2007"
      },
      "CompletionDateStruct": {
        "CompletionDate": "August 2009",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "March 13, 2007",
      "StudyFirstSubmitQCDate": "March 13, 2007",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "March 14, 2007",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 20, 2007",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 22, 2007",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "LeadSponsor": {
        "LeadSponsorName": "University of Salamanca",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Clinical trial based on the use of a new therapeutic strategy (MSC infusion) for the treatment of patients who have developed a GVHD refractory to the usual therapeutic measures after undergoing an allogenic hematopoietic stem cell transplant.",
      "DetailedDescription": "This is a multicenter, single dose study of allogenic mesenchymal stem cell (1-2 x 10^6 MSC/Kg recipient´s bodyweight).\n\nMSC will be infused, by a central venous catheter, to patients diagnosed with GVHD refractory to first-line or subsequent treatment.\n\nAll patients will receive the same treatment. MSC suspension will be obtained from the bone marrow aspiration of a family donor and expanded in-vitro in a specific culture medium with autologous donor´s serum and with no animal-derived products."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Graft-vs-Host Disease (GVHD)"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Graft-vs-host disease (GVHD)",
          "Mesenchymal stem cell (MSC)",
          "Allogeneic hematopoietic stem cell transplant",
          "Allotransplant",
          "Allogenic",
          "Refractory",
          "CSM/EICH2005"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "15"
      }
    },
    "ArmsInterventionsModule": {
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Procedure",
            "InterventionName": "Mesenchymal stem cell (MSC)"
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Determine the safety/efficacy of expanded in-vitro allogenic mesenchymal stem cell infusion in patients developing a GVHD refractory to the usual therapeutic measures after undergoing an allogeneic hematopoietic stem cell transplant."
          },
          {
            "PrimaryOutcomeMeasure": "Efficacy will be evaluated in terms of GVHD response."
          },
          {
            "PrimaryOutcomeMeasure": "Safety will be evaluated in terms of incidence of adverse events and toxicities related to the administration of MSC."
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Evaluation of infectious complications after MSC infusion."
          },
          {
            "SecondaryOutcomeMeasure": "Analyse the influence of MSC infusion on the posttransplant relapse risk of the base disease."
          },
          {
            "SecondaryOutcomeMeasure": "Study the influence of MSC infusion on DFS and OS."
          },
          {
            "SecondaryOutcomeMeasure": "Determine MSC grafted into the bone marrow (or in other organs)."
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with hematological malignancies who had been undergone an allogenic hematopoietic stem cell transplant and diagnosed with GVHD refractory to a usual treatment.\nAdequate cardiac function with no evidence of uncontrolled high blood pressure,congestive heart failure, angina pectoris, acute myocardial infarction within 6 months prior to the process.\nAdequate pulmonary function with no evidence of chronic obstructive or severe restrictive pulmonary disease.\nPatients with ages between 18 and 65 years.\nSignature of informed consent form is required to be done by patient and donor.\n\nExclusion Criteria:\n\nPatients whose hematopathology has not been controlled by the transplant or is in progress.\nPatients with bacterial, viral or fungal infection not being controlled with the adequate treatment.\nPatients with an inadequate cardiac or pulmonary function.\nPatients who, in the investigator´s point of view, are not in situation to tolerate the treatment.\nPatients who do not have the required donor (HLA-identical sibling donor and not HLA-identical sibling donor).\nPregnant females or childbearing potential who are not on adequate contraceptive measures.\nPatients <18 or >65 years.\nPatients who do not sign the informed consent.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Mercedes Comas, CRA",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+(034)915545476",
            "CentralContactPhoneExt": "29",
            "CentralContactEMail": "mercedes.comas@logitest.es"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Consuelo del Cañizo, MD",
            "OverallOfficialAffiliation": "Haematology Service, University Hospital of Salamanca",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "José A Pérez-Simón, MD",
            "OverallOfficialAffiliation": "Haematology Service, University Hospital of Salamanca",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "David Varcárcel Ferrerías, MD",
            "OverallOfficialAffiliation": "Haematology Service, Santa Creu i Sant Pau Hospital, Barcelona",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Carmen Martínez Muñoz, MD",
            "OverallOfficialAffiliation": "Haematology Service, Clinic i Provincial Hospital, Barcelona",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "José Rifón Roca, MD",
            "OverallOfficialAffiliation": "Haematology Service, University Clinic of Navarra",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University Clinic of Navarra",
            "LocationStatus": "Recruiting",
            "LocationCity": "Navarra",
            "LocationState": "Pamplona",
            "LocationZip": "31080",
            "LocationCountry": "Spain",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "José Rifón Roca, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "Santa Creu i Sant Pau Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Barcelona",
            "LocationZip": "08025",
            "LocationCountry": "Spain",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "David Varcárcel Ferrerías, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "Clinic i Provincial Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Barcelona",
            "LocationZip": "08036",
            "LocationCountry": "Spain",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Carmen Martínez Muñoz, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "University Hospital of Salamanca",
            "LocationStatus": "Recruiting",
            "LocationCity": "Salamanca",
            "LocationZip": "37007",
            "LocationCountry": "Spain",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Consuelo del Cañizo, MD",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "José A Pérez-Simón, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "21393326",
            "ReferenceType": "derived",
            "ReferenceCitation": "Pérez-Simon JA, López-Villar O, Andreu EJ, Rifón J, Muntion S, Diez Campelo M, Sánchez-Guijo FM, Martinez C, Valcarcel D, Cañizo CD. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica. 2011 Jul;96(7):1072-6. doi: 10.3324/haematol.2010.038356. Epub 2011 Mar 10."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000006086",
            "ConditionMeshTerm": "Graft vs Host Disease"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M8341",
            "ConditionBrowseLeafName": "Graft vs Host Disease",
            "ConditionBrowseLeafAsFound": "Graft vs Host Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T2832",
            "ConditionBrowseLeafName": "Homologous Wasting Disease",
            "ConditionBrowseLeafAsFound": "Graft vs Host Disease",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}